Basics Eli Lilly & Co. Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products. IPO Date: January 2, 1990 Sector: Healthcare Industry: Pharma Market Cap: $725.2B Activated in VL: True Average Daily Range Avg Daily Range: $1.79 | 0.94% Avg Daily Range (30 D): $10.74 | 1.38% Avg Daily Range (90 D): $9.76 | 1.29% Institutional Daily Volume Avg Daily Volume: 4.35M Avg Daily Volume (30 D): 2.85M Avg Daily Volume (90 D): 3.49M Trade Size Avg Trade Size (Sh.): 119 Avg Trade Size (Sh.) (30 D): 24 Avg Trade Size (Sh.) (90 D): 26 Institutional Trades Total Inst.Trades: 86,670 Avg Inst. Trade: $9.32M Avg Inst. Trade (30 D): $80.19M Avg Inst. Trade (90 D): $72.21M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 15 Market Closing Trades Avg Closing Trade: $82.64M Avg Closing Trade (30 D): $357.85M Avg Closing Trade (90 D): $332.39M Avg Closing Volume: 414.28K     News Oct 22, 2025 @ 12:36 PM Big Money Exits: Iconic Pharma Stock Sold by High-... Source: Jake Lerch Oct 20, 2025 @ 1:00 PM Weight Loss Drugs Market Set to Reach USD 50.26 Bi... Source: Sns Insider Oct 19, 2025 @ 11:01 PM Investment Advisor Goes All-In on Big Pharma Stock... Source: Jake Lerch Oct 19, 2025 @ 9:33 PM Large Wealth Advisor Trims Exposure to Red-Hot Dig... Source: Jake Lerch Oct 19, 2025 @ 3:10 PM Got $5,000? 2 Stocks to Buy Now and Hold for the L... Source: Manali Pradhan Financials   TTM Q2 2025 Q1 2025 Basic EPS $15.35 $6.3 $3.07 Diluted EPS $15.3 $6.29 $3.06 Revenue $ 53.26B $ 15.56B $ 12.73B Gross Profit $ 44.01B $ 13.11B $ 10.5B Net Income / Loss $ 13.8B $ 5.66B $ 2.76B Operating Income / Loss $ 16.86B $ 6.78B $ 3.46B Cost of Revenue $ 9.25B $ 2.45B $ 2.22B Net Cash Flow $ 152.3M $ 282.6M $ -175.1M PE Ratio 52.88